| Ms Kimberly Ann Sweeney, RPH | |
|
3300 Highway 10 E, Moorhead, MN 56560-2505 | |
| (218) 236-0345 | |
| (218) 236-0354 |
| Full Name | Ms Kimberly Ann Sweeney |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3300 Highway 10 E, Moorhead, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154101897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15341 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kimberly Ann Sweeney, RPH 3300 Highway 10 E, Moorhead, MN 56560-2505 Ph: (218) 236-0345 | Ms Kimberly Ann Sweeney, RPH 3300 Highway 10 E, Moorhead, MN 56560-2505 Ph: (218) 236-0345 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology and oncology supportive care, announced interim results from its ongoing MuGard Phase 4 clinical trial in oral mucositis.
A study in The Journal of Cell Biology by scientists at the University of Massachusetts Medical School reveals important new details about the inner workings of the CRISPR-Cas9 machinery in live cells that may have implications for the development of therapeutics that use the powerful gene editing tool.
Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.
Two-way communication between cancer cells appears to be key to their becoming motile, clustering and spreading through metastasis, according to Rice University scientists.
During about the last 20 years, the risk of delivery-related death at birth or shortly thereafter for term infants has decreased nearly 40 percent in Scotland, with the largest contributing factor being a decrease in the number of deaths caused by a lack of oxygen for the baby during the childbirth process, according to a study in the August 12 issue of JAMA.
› Verified 1 days ago
Mr. Rollin Elis Wiger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Highway 10 E, Moorhead, MN 56560 Phone: 218-236-5268 Fax: 218-233-6799 | |
Dr. Kristie Marie Lockhart, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3301 Highway 10 E, T-0658, Moorhead, MN 56560 Phone: 218-233-2953 Fax: 218-233-2953 | |
Wendy A Gress, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Main Ave, Moorhead, MN 56560 Phone: 218-236-0252 Fax: 218-236-0892 | |
Andrea Kaye Plath, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Highway 10 E, Moorhead, MN 56560 Phone: 218-236-0345 | |
Corey Wayne Burnside, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Hwy 10 E, Cashwise Pharmacy #15, Moorhead, MN 56560 Phone: 218-236-0345 Fax: 218-236-0354 | |
Erianne Siena Gibson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 40th Ave S, Moorhead, MN 56560 Phone: 218-359-4007 Fax: 218-359-4010 |